Endoplasmic Reticulum Protein 44 (ERP44) (Middle Region) Peptid
ERP44
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle ERP44 Produkte
- ERP44 (Endoplasmic Reticulum Protein 44 (ERP44))
- Protein Region
- Middle Region
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-TXNDC4 antibody (Catalog #: ARP58726_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Aufreinigung
- Purified
-
-
- Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Konzentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- ERP44 (Endoplasmic Reticulum Protein 44 (ERP44))
- Hintergrund
-
TXNDC4 mediates thiol-dependent retention in the early secretory pathway, forming mixed disulfides with substrate proteins through its conserved CRFS motif. TXNDC4 inhibits the calcium channel activity of ITPR1. TXNDC4 may have a role in the control of oxidative protein folding in the endoplasmic reticulum. TXNDC4 is required to retain ERO1L and ERO1LB in the endoplasmic reticulum.
Alias Symbols: ERP44, KIAA0573, PDIA10, TXNDC4
Protein Interaction Partner: ERO1L,ERO1LB,ITPR1,CD40,ERO1L,ERO1LB,UIMC1,USP32,USP46
Protein Size: 406 - Molekulargewicht
- 45 kDa
- Gen-ID
- 23071
- NCBI Accession
- NM_015051, NP_055866
- UniProt
- Q9BS26
-
Sie sind hier:
